SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,062 | +7.1% | 248 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $28,056 | +239.3% | 245 | +308.3% | 0.00% | – |
| Q1 2023 | $8,269 | +87.7% | 60 | +76.5% | 0.00% | – |
| Q4 2022 | $4,405 | +46.8% | 34 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 34 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 34 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 34 | -17.1% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 41 | +7.9% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -66.7% | 38 | +8.6% | 0.00% | – |
| Q4 2020 | $6,000 | +200.0% | 35 | +66.7% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 21 | +10.5% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 19 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |